Octane News

Cocoon Wins Silver in Spark Design Awards

New York, November 20, 2017 – Octane’s Cocoon automated bioreactor is this year’s recipient of the Silver prize in the Health category of the Spark Design Awards, an 11-year-old competition that recognizes modern designs which innovate, change the game and, in some way, help humanity or the environment.

Cocoon certainly ticks off all these boxes. This breakthrough bioreactor technology automates the manufacturing of patient-specific cell and tissue therapies, taking personalized regenerative medicine to the next level.

“We at Octane are so proud of Cocoon and we are grateful to the jurors at Spark for recognizing Cocoon’s ability to transform regenerative medicine,” says Octane CEO Tim Smith.

Cell therapy for personalized medicine has demonstrated great potential for fighting diseases such as cancer. But current manual processes for producing patient-specific cells are time-consuming, inefficient and potentially prone to contamination.

With Cocoon, these manual processes are automated and accelerated to produce breakthrough patient-specific treatments that are economical, safe and commercially scalable.

“Fundamentally, the Cocoon system optimizes the biology of growing healthy cells and tissues for re-implantation into the patient,” says Smith. “It truly is a game changer in regenerative medicine.”

For press inquiries please contact Renee Thibodeau.
613-634-6345 x200

About the Spark Awards

The Spark mission is to promote better living through better design. Spark Awards are tri-annual affairs, with different design categories judged in June and November in San Francisco and December in Hong Kong. Both design professionals and students actively participate throughout the year. Learn more about the Spark organization and mission at the landing page at www.sparkawards.com

About Octane Technology

Cocoon™ is a patient-scale cell therapy system that forms the core of a series of versatile cell and tissue therapy production systems. Unlike other bioreactor systems, this platform integrates multiple steps, including upstream and downstream processing. From cell source isolation and cell expansion, through to cell collection, cell washing and final product formation – all in a closed, single-use disposable cassette

Coupled with advanced bioreactors, biosensor feedback and innovative cell scaffolds, this cell culture and tissue engineering platform opens up an array of clinical applications. Cocoon is an integrated turnkey production solution that can be configured as a compact but powerful system with a small footprint, or as a multi-patient system for ultra-efficient, enterprise-level deployment. Please read more about our game-changing innovations in regenerative medicine .

Recent News

Octane Completes Major Expansion of State-of-the-Art Facility in Kingston, Ontario

Kingston, Ontario, 15 December 2020 – Octane Medical Group has expanded its state-of-the-art facility in Kingston, Ontario Canada. The 40,000-square-foot ...

Octane Wins 2020 Edison Award in Cellular Research for AUTOGRAFTA™ Synthesis of Living Grafts for Skeletal Reconstruction

Maine, USA, 18 March 2020 – Octane innovations in tissue engineering, personalized medicine and automated living implant production have earned ...

Lonza Acquires a Controlling Stake in Octane Biotech to Further Develop Cocoon™ Autologous Technology

Basel, Switzerland, 29 October 2018 – Lonza announced today the acquisition of a controlling stake in Octane Biotech, with the ...

Octane’s Cocoon Technology Wins Prestigious iF Design Award

Hannover, Germany, 09 March 2018 – iF International Forum Design GmbH has recognized Octane’s Cocoon technology with this year’s iF ...

Octane and Lonza Announce Exclusive Collaboration to Evaluate Groundbreaking Autologous Cell Therapy Technology

Basel, Switzerland, and Ontario, Canada, 23 June 2015 – Lonza Group Ltd. in Switzerland and Octane Biotech Inc. in Canada ...